Triple negative breast cancer
Conditions
Interventions
Triple negative breast cancer:matrine injection
Sponsors
The First Affiliated Hospital of Henan University
Eligibility
Sex/Gender
Female
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: (1) patients with tumor free survival of triple negative breast cancer; (2) patients aged 18-65 years (subject to the time of signing the informed consent); (3) patients who voluntarily participate in and sign the informed consent.
Exclusion criteria
Exclusion criteria: (1) patients with diabetes; (2) patients with other diseases under treatment; (3) patients with chemotherapy or radiotherapy less than 3 months; (4) patients with immune related drugs, radiation, nuclear medicine or surgery in the first three months; (5) patients with malignant tumors in the first five years (without complete cure of cervical carcinoma in situ, basal cells or squamous epithelial cells skin). Patients with cancer (6) received drug treatment within 7 days before admission. (7) during pregnancy and lactation; (8) those who have received blood transfusion of whole blood or component blood within 4 months; (9) those who are positive for any one of human immunodeficiency virus antibody, syphilis antibody and hepatitis C antibody; (10) those who are currently affected by intravenous transfusion and blood sampling diseases; (11) those who have participated in other clinical trials within 3 months before entering into the group; (12) those who are not considered suitable for entering the group or This test may not be completed for other reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum metabolites; | — |
Countries
China
Contacts
Public ContactShi Bingshuai
The First Affiliated Hospital of Henan University
Outcome results
None listed